Trial intelligence / Profile preview

MIELS: MR With Non-Perfusion Imaging for Endovascular Treatment in LVO Stroke

NCT05735301Recruiting

Sponsor
Tianjin Huanhu Hospital
Start
Jan 2019
Primary completion
Sep 2024
Countries
1
01

Overview

Randomised, open-label trial in ischemic stroke and Large vessel occlusion (LVO) (2 arms), sponsored by Tianjin Huanhu Hospital. Primary endpoint: Functionally independent outcome at 90 days. Started Jan 2019; status: recruiting.

02

Conditions

ischemic strokeLarge vessel occlusion (LVO)

Beyond the preview

Go deeper on NCT05735301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05735301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call